Hematologist – Malignant Hematology – Lymphoma Program

Position Summary

The Department of Medicine and the Division of Hematology (Ottawa Blood Disease Centre) at the University of Ottawa and The Ottawa Hospital are looking for a locum hematologist to provide coverage during an upcoming temporary leave within our lymphoma program from Apr 1, 2026 to Jan 31, 2027.

Responsibilities:
We are currently seeking applicants with a clinical focus in in lymphoproliferative disorders to provide coverage during an upcoming temporary leave. While a specific area of interest within lymphoproliferative disorders is welcome, the successful candidate will see a mix of lymphoma patients in their clinics. Inpatient and outpatient care is provided primarily at the Ottawa Hospital, General Campus; an additional half-day clinic per week is held at the Irving Greenberg Cancer Centre, at the Queensway Carleton Hospital. As part of practicing in an academic setting, the incumbent will participate in training and supervision of trainees and the divisional on-call rotation schedule.

Qualifications

The ideal candidate will have expertise in lymphoproliferative disorders. The position is within Ontario’s Alternate Funding Plan for malignant hematologists (POAFP) and remuneration is competitive nationally.

The successful candidate must hold an MD degree; be a member of, or be eligible to be a member of, the Canadian Medical Protective Association; have, or be eligible for certification in Hematology by the Royal College of Physicians and Surgeons of Canada, and have, or be eligible for, licensure in Ontario. The successful candidate will be eligible to hold an academic appointment at the rank of an Assistant Professor or higher at the University of Ottawa. Academic rank will be commensurate with the candidate’s qualifications and experience.

The University of Ottawa and The Ottawa Hospital are bilingual institutions and therefore in the case of potentially successful candidates of equal ability, a bilingual (French/English) candidate would be preferred.

Additional Information

The Division of Hematology (The Ottawa Blood Disease Centre) is a large group of 43 faculty that
work within a group practice plan model within the University of Ottawa and The Ottawa Hospital
academic centre. The Division has three well-defined and successful clinical and research
programs: Malignant Hematology, Thrombosis and Benign Hematology. All faculty in the Hematology Division are co-located at the General Campus of The Ottawa Hospital.

The lymphoproliferative group currently consists of 7 faculty who see >600 new lymphoma and CLL patients per year, offers a clinical lymphoma fellowship program, and conducts a mix of clinical research activities. The Lymphoproliferative Disease Group partners with the Transplant and Cell Therapy program to provide hematopoietic cell transplants and immune effector cell therapies, with both commercial and research product activity.

Academically, the division and department support undergraduate and postgraduate training, including subspecialty fellowship trainees in all three of our programs. Members have access to research services through the Office of Research Support and the Ottawa Hospital Research Institute houses experts in broad areas of clinical epidemiology, statistical support, transfusion medicine research, patient decision-making, and knowledge translation. The Department of Medicine supports clinical academic work through a competitive academic incentive program

The Ottawa Hospital is a 1150 bed tertiary-care hospital serving Eastern Ontario and Western Quebec at four inpatient sites (Civic, General, Heart Institute, and the Rehabilitation Centre) and one ambulatory centre (Riverside). There are approximately 50,000 inpatient admissions, 160,000 emergency visits and over one million outpatient visits annually.

Ground-breaking medical research is conducted through The Ottawa Hospital Research Institute (OHRI) and the University of Ottawa Heart Institute. We rank 5th in Canada for competitive, peer-reviewed grants from the prestigious Canadian Institutes of Health Research. Over 2,300 researchers are publishing more than 2,200 studies yearly, with hundreds being high-impact publications (top 10% or citations).

The Department of Medicine is a research-intensive Department. Members currently hold 25 University Research Chairs. The Department receives approximately $60 million per year in external research funding and members publish approximately 1200 peer-reviewed publications annually.

The Faculty of Medicine is a nationally recognized leader, ranked among Canada’s top-tier medical faculties. As the most research-intensive Faculty at the University of Ottawa, the Faculty of Medicine contributes significantly to the University being ranked 5th in the country for total research revenues (Research InfoSource), routinely 2nd or 3rd in Canada for research intensity in Medicine/Science grants (McLean’s), 4th in Canada for citations (2022 THE rankings) and 1st for overall growth in Tri-council funding over the past two decades. The University of Ottawa is the largest bilingual (English/French) university in the world and the Faculty of Medicine first and largest bilingual medical school in Canada. The Faculty of Medicine has a long history of conducting the highest quality basic and clinical research, in close partnership with five affiliated academic hospitals and six research institutes. The Web of Science recently published a list of the most highly cited researchers in the world, where seven out of eight researchers identified from the uOttawa are from the Faculty of Medicine. Together, these remarkable achievements are a strong testament to the competitiveness and excellence of our Faculty that extend to all our educational programs.

The City of Ottawa provides a thriving multicultural and bilingual environment. Ottawa boasts numerous cultural activities as well as readily accessible sporting and natural resources, making it an ideal family and healthy living environment.

The Department of Medicine is committed to upholding the values of equity, diversity, inclusion, and accessibility in our living, learning, and work environments. We encourage qualified applicants from all groups with historical and/or current barriers to equity to apply. Upon request, accommodations due to a disability are available throughout the recruitment process.

Please note Canadian citizens and permanent residents will be given priority. We sincerely thank all applicants for their interest; however, only those selected for an interview will be contacted.

Terms of Employment

The income for this position is derived from clinical billings (fee-for-service).

Applications

Please forward a 1-2 page letter of intent, 3 references (who will not be contacted without permission) and a CV to Dr Marc Carrier, Head Division of Hematology, , Department of Medicine of The Ottawa Hospital and University of Ottawa at mcarrier@toh.ca.

Closing Date: Jan 26, 2026

Last updated on: January 7th, 2026